New insights into the effects of serotonin on Parkinson's disease and depression through its role in the gastrointestinal tract

• Published in: Spanish Journal of Psychiatry and Mental Health
• Main Authors: Sancho-Alonso, María, Sarriés-Serrano, Unai, Miquel-Rio, Lluis, Yanes Castilla, Claudia, Paz, Verónica, Meana, José Javier, Perello, Mario, Bortolozzi, Analia
• Format: Journal Article
• Language: English
• Published: Spain Elsevier España S.L.U 09.07.2024
• Subjects: Depression; Gut–brain axis; Parkinson's disease; Serotonin; α-Synuclein; α-Synuclein; Depression; Gut–brain axis; Parkinson's disease; Serotonin; Gut-brain axis; Parkinson’s disease
• ISSN: 2950-2853; 2950-2853
• DOI: 10.1016/j.sjpmh.2024.07.002

Neuropsychiatric and neurodegenerative disorders are frequently associated with gastrointestinal (GI) co-pathologies. Although the central and enteric nervous systems (CNS and ENS, respectively) have been studied separately, there is increasing interest in factors that may contribute to conditions affecting both systems. There is compelling evidence that serotonin (5-HT) may play an important role in several gut–brain disorders. It is well known that 5-HT is essential for the development and functioning of the CNS. However, most of the body's 5-HT is produced in the GI tract. A deeper understanding of the specific effects of enteric 5-HT on gut–brain disorders may provide the basis for the development of new therapeutic targets. This review summarizes current data focusing on the important role of 5-HT in ENS development and motility, with particular emphasis on novel aspects of 5-HT signaling in conditions where CNS and ENS comorbidities are common, such as Parkinson's disease and depressive disorders.